VC
KALA icon

Vivo Capital’s KALA BIO KALA Stock Holding History

Vivo Capital’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-315
Closed -$5.3M – 64
2021
Q1 		$5.3M Hold
315
– – 0.19% 53
2020
Q4 		$5.33M Hold
315
– – 0.24% 49
2020
Q3 		$5.9M Hold
315
– – 0.34% 49
2020
Q2 		$8.27M Hold
315
– – 0.59% 35
2020
Q1 		$6.92M Buy
+315
New +$5.03M 0.63% 37
2019
Q3 		– Sell
-418
Closed -$6.65M – 19
2019
Q2 		$6.65M Hold
418
– – 0.62% 33
2019
Q1 		$8.63M Hold
418
– – 0.86% 30
2018
Q4 		$5.1M Hold
418
– – 0.65% 31
2018
Q3 		$10.3M Hold
418
– – 1.04% 24
2018
Q2 		$14.3M Hold
418
– – 1.85% 15
2018
Q1 		$16.5M Sell
418
-46
-10% -$1.75M 2.34% 13
2017
Q4 		$21.4M Hold
464
– – 4.59% 9
2017
Q3 		$26.5M Buy
+464
New +$25.5M 5.35% 5

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vivo Capital's KALA Position: Q2 2021 in Review

Vivo Capital sold out of KALA BIO (KALA) in Q2 2021, closing a stake of 315 shares — an estimated $5.3M sold.

Vivo Capital first reported a position in KALA in Q3 2017 and held it in 13 quarters. The position peaked at $26.5M in Q3 2017. 97 funds tracked by Wall St. Rank hold KALA as of Q2 2021.

  • Vivo Capital reported no remaining KALA BIO position as of Q2 2021 after selling out during the quarter.
  • Vivo Capital sold 315 KALA BIO shares in Q2 2021, an estimated $5.3M.
  • Vivo Capital first reported a position in KALA BIO in Q3 2017 and held it in 13 quarters.
  • Vivo Capital's KALA BIO position peaked at $26.5M in Q3 2017.
  • 97 funds tracked by Wall St. Rank held KALA BIO as of Q2 2021.

Based on Vivo Capital's 13F filing for Q2 2021, filed 16 Aug 2021.